Chumakov Federal Scientific Center for Research and Development of Immune-and-Biological Products
Quick facts
Phase 3 pipeline
- Vaccine for intramuscular injection · Infectious Diseases
This vaccine stimulates the body's immune system to produce a specific response against the target pathogen.
Competitive intelligence
For the full portfolio CI brief — phase mix, recent regulatory actions, upcoming PDUFA dates, patent timeline, class-overlap with competitors:
- Chumakov Federal Scientific Center for Research and Development of Immune-and-Biological Products portfolio CI brief
- Chumakov Federal Scientific Center for Research and Development of Immune-and-Biological Products pipeline updates RSS
Frequently asked questions about Chumakov Federal Scientific Center for Research and Development of Immune-and-Biological Products
What is Chumakov Federal Scientific Center for Research and Development of Immune-and-Biological Products's pipeline?
Chumakov Federal Scientific Center for Research and Development of Immune-and-Biological Products has 1 drugs in Phase 3, 0 in Phase 2, 0 in Phase 1. Late-stage candidates include Vaccine for intramuscular injection.
Related
- Sector hub: All tracked pharma companies